Biosensor-based affinities and binding kinetics of small molecule antagonists to the adenosine A2Areceptor reconstituted in HDL like particles
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Biosensor-based affinities and binding kinetics of small molecule antagonists to the adenosine A2Areceptor reconstituted in HDL like particles
Authors
Keywords
-
Journal
FEBS LETTERS
Volume 589, Issue 13, Pages 1399-1405
Publisher
Wiley
Online
2015-05-03
DOI
10.1016/j.febslet.2015.04.030
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Binding Kinetics of ZM241385 Derivatives at the Human Adenosine A2AReceptor
- (2014) Dong Guo et al. ChemMedChem
- Kinetics of the early events of GPCR signalling
- (2014) Roslin J. Adamson et al. FEBS LETTERS
- High-resolution structure of the human GPR40 receptor bound to allosteric agonist TAK-875
- (2014) Ankita Srivastava et al. NATURE
- Structure of class C GPCR metabotropic glutamate receptor 5 transmembrane domain
- (2014) Andrew S. Doré et al. NATURE
- Structure of a Class C GPCR Metabotropic Glutamate Receptor 1 Bound to an Allosteric Modulator
- (2014) H. Wu et al. SCIENCE
- Biophysical Fragment Screening of the β1-Adrenergic Receptor: Identification of High Affinity Arylpiperazine Leads Using Structure-Based Drug Design
- (2013) John A. Christopher et al. JOURNAL OF MEDICINAL CHEMISTRY
- Discovery of β2 Adrenergic Receptor Ligands Using Biosensor Fragment Screening of Tagged Wild-Type Receptor
- (2013) Tonia Aristotelous et al. ACS Medicinal Chemistry Letters
- HDL-like discs for assaying membrane proteins in drug discovery
- (2012) Cédric Fiez-Vandal et al. BIOPHYSICAL CHEMISTRY
- Discovery of 1,2,4-Triazine Derivatives as Adenosine A2A Antagonists using Structure Based Drug Design
- (2012) Miles Congreve et al. JOURNAL OF MEDICINAL CHEMISTRY
- Biophysical Mapping of the Adenosine A2AReceptor
- (2011) Andrei Zhukov et al. JOURNAL OF MEDICINAL CHEMISTRY
- Trends in the exploitation of novel drug targets
- (2011) Mathias Rask-Andersen et al. NATURE REVIEWS DRUG DISCOVERY
- Biacore analysis with stabilized G-protein-coupled receptors
- (2010) Rebecca L. Rich et al. ANALYTICAL BIOCHEMISTRY
- Nanodiscs allow the use of integral membrane proteins as analytes in surface plasmon resonance studies
- (2010) Julian M. Glück et al. ANALYTICAL BIOCHEMISTRY
- Application of Fragment-Based Drug Discovery to Membrane Proteins: Identification of Ligands of the Integral Membrane Enzyme DsbB
- (2010) Virginie Früh et al. CHEMISTRY & BIOLOGY
- Drug–target residence time: critical information for lead optimization
- (2010) Hao Lu et al. CURRENT OPINION IN CHEMICAL BIOLOGY
- The properties of thermostabilised G protein-coupled receptors (StaRs) and their use in drug discovery
- (2010) Nathan Robertson et al. NEUROPHARMACOLOGY
- Membrane protein assembly into Nanodiscs
- (2009) Timothy H. Bayburt et al. FEBS LETTERS
- Purification and Functional Reconstitution of Monomeric μ-Opioid Receptors
- (2009) Adam J. Kuszak et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Nanodiscs for Immobilization of Lipid Bilayers and Membrane Receptors: Kinetic Analysis of Cholera Toxin Binding to a Glycolipid Receptor
- (2008) Jonas Borch et al. ANALYTICAL CHEMISTRY
- Rapid Incorporation of Functional Rhodopsin into Nanoscale Apolipoprotein Bound Bilayer (NABB) Particles
- (2008) Sourabh Banerjee et al. JOURNAL OF MOLECULAR BIOLOGY
- The adenosine A1 receptor antagonist SLV320 reduces myocardial fibrosis in rats with 5/6 nephrectomy without affecting blood pressure
- (2007) P Kalk et al. BRITISH JOURNAL OF PHARMACOLOGY
- Quantifying the association and dissociation rates of unlabelled antagonists at the muscarinic M3 receptor
- (2006) Mark R Dowling et al. BRITISH JOURNAL OF PHARMACOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started